APA (7th ed.) Citation

Mariane Teodoro Fernandes, Jacob J Adashek, Carmelia Maria Noia Barreto, Ana Cláudia Barbin Spinosa, Barbara de Souza Gutierres, Gilberto Lopes, . . . Pedro Nazareth Aguiar Jr. (2018). A paradigm shift for the treatment of hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HER2-) advanced breast cancer: A review of CDK inhibitors. BioExcel Publishing Ltd.

Chicago Style (17th ed.) Citation

Mariane Teodoro Fernandes, Jacob J Adashek, Carmelia Maria Noia Barreto, Ana Cláudia Barbin Spinosa, Barbara de Souza Gutierres, Gilberto Lopes, Auro del Giglio, and Pedro Nazareth Aguiar Jr. A Paradigm Shift for the Treatment of Hormone Receptor-positive, Human Epidermal Growth Factor Receptor 2-negative (HR+/HER2-) Advanced Breast Cancer: A Review of CDK Inhibitors. BioExcel Publishing Ltd, 2018.

MLA (9th ed.) Citation

Mariane Teodoro Fernandes, et al. A Paradigm Shift for the Treatment of Hormone Receptor-positive, Human Epidermal Growth Factor Receptor 2-negative (HR+/HER2-) Advanced Breast Cancer: A Review of CDK Inhibitors. BioExcel Publishing Ltd, 2018.